Market Value511,320,000
Total Holdings55
File Date2020-11-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
FENC / Fennec Pharmaceuticals Inc.
TCON / TRACON Pharmaceuticals, Inc.
MTEM / Molecular Templates, Inc.
MCRB / Seres Therapeutics, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
TCDA / Tricida Inc
QURE / uniQure N.V.
BTAI / BioXcel Therapeutics, Inc.
CNCE / Concert Pharmaceuticals Inc
XFOR / X4 Pharmaceuticals, Inc.
AGLE / Aeglea BioTherapeutics Inc
ONCT / Oncternal Therapeutics, Inc.
OM / Outset Medical, Inc.
VSTM / Verastem, Inc.
KALA / KALA BIO, Inc.
CMRX / Chimerix, Inc.
PCVX / Vaxcyte, Inc.
ODT / Odonate Therapeutics Inc
MYOV / Myovant Sciences Ltd
INFI / Infinity Pharmaceuticals Inc.
CDXS / Codexis, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ASRT / Assertio Holdings, Inc.
TARA / Protara Therapeutics, Inc.
AFIB / Acutus Medical, Inc.
CDTX / Cidara Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
MEIP / MEI Pharma, Inc.
MGTA / Magenta Therapeutics Inc
MRUS / Merus N.V.
FGEN / FibroGen, Inc.
ADMS / Adamas Pharmaceuticals Inc
CRNX / Crinetics Pharmaceuticals, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
AVTX / Avalo Therapeutics, Inc.
SIOX / Sio Gene Therapies Inc.
CLDX / Celldex Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
CFRX / ContraFect Corp
LQDA / Liquidia Corporation
KNSA / Kiniksa Pharmaceuticals, Ltd.
CCXI / ChemoCentryx Inc
STXS / Stereotaxis, Inc.
ATXI / Avenue Therapeutics, Inc.
CRDF / Cardiff Oncology, Inc.
APTO / Aptose Biosciences Inc.
STRO / Sutro Biopharma, Inc.
LUMO / Lumos Pharma, Inc.
KZR / Kezar Life Sciences, Inc.
NLTX / Neoleukin Therapeutics, Inc.
ARDX / Ardelyx, Inc.
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
MGNX / MacroGenics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
BHVN / Biohaven Ltd.
FULC / Fulcrum Therapeutics, Inc.
NERV / Minerva Neurosciences, Inc.
TELA / TELA Bio, Inc.
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
CYTK / Cytokinetics, Incorporated
EPIX / ESSA Pharma Inc.
ETON / Eton Pharmaceuticals, Inc.
HROW / Harrow, Inc.
FBIO / Fortress Biotech, Inc.
OCUL / Ocular Therapeutix, Inc.
TGTX / TG Therapeutics, Inc.
XOMA / XOMA Royalty Corporation